People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support.
Presentation summary:Cord blood monocytes differ from monocytes in adult blood and appear to be uniquely suited for use as source material from which to derive new therapeutics for treatment of brain disorders. DUOC-01, a cellular therapy that promotes myelination, is undergoing testing to augment umbilical cord blood transplants in children with leukodystrophies. We are studying whether infusions of cord blood cells could have efficacy in acquired brain injuries. Clinical studies to date have demonstrated safety and efficacy of intravenous infusions of autologous and sibling cord blood in hypoxic ischemic encephalopathy, cerebral palsy, congenital hydrocephalus and autism, and acute ischemic stroke. Further development of these therapies using allogeneic cord blood products can expand access to these therapies for all patients in need. While you're there, be sure to ask our product experts how we can create better outcomes for you.
About Share the Science
Share the Science is a free series designed to bring you powerful presentations by the top experts in cellular therapy. Supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cell therapy.
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Dr. Joanne Kurtzberg is the Director, Pediatric Blood and Marrow Transplant Program at Duke University School of Medicine, Director of the Marcus Center for Cellular Cures, Director of the Carolinas Cord Blood Bank, Co-Director of Stem Cell Laboratory and the President of Cord Blood Association.
Dr. Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplant, umbilical cord blood banking and transplant, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine. Over the last two decades, Dr. Kurtzberg has established an internationally known pediatric transplant program; one of the largest unrelated donor cord blood banks, the Carolinas Cord Blood Bank, in the world; and the Marcus Center for Cellular Cures (MC3) at Duke.
Dr. Kurtzberg has published more than 300 peer-reviewed papers, multiple chapters, and scientific reviews. She is a member of the American Society of Hematology, the American Association of Blood and Marrow Transplantation, the American Society of Pediatric Hematology/Oncology, the International Society of Cellular Therapies, the Pediatric Blood and Marrow Transplant Consortium (PBMTC), and other organizations. She has served on the Board of the Foundation of Accreditation of Cellular Therapies, Advisory Council of Blood Stem Cell Transplantation to Health and Human Services. Dr. Kurtzberg was awarded a Lifetime Achievement Award from the PBMTC in 2012.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
11300 Switzer Road, Overland Park, KS 66210
© Copyright 2019 WellSky. All rights reserved.